论文部分内容阅读
目的观察消化系统肿瘤内出血患者应用奥曲肽治疗的临床效果。方法选取消化系统肿瘤内出血患者43例为研究对象,分为对照组22例,观察组21例。对照组给予洛赛克治疗,观察组给予奥曲肽治疗,治疗期间观察2组患者停止出血时间,同时记录2组的止血率及不良反应发生情况。结果观察组出血停止时间为(21.4±7.8)h,短于对照组的(34.7±15.6)h(P<0.05);观察组24 h止血率为85.7%,高于对照组的50.0%(P<0.05)。2组不良反应发生率比较差异无统计学意义(P>0.05)。结论临床上应用奥曲肽对消化系统肿瘤内出血患者进行治疗,不仅可以缩短止血时间,还能使止血率得到有效提高,具有一定的推广和应用价值。
Objective To observe the clinical effect of octreotide treatment in patients with digestive system tumor hemorrhage. Methods Forty-three patients with intra-hemorrhage of digestive system tumor were selected as study object, divided into control group (n = 22) and observation group (n = 21). The control group was treated with Losec. The observation group was treated with octreotide, and the bleeding time was observed during the treatment in both groups. At the same time, the hemostasis rate and adverse reactions of the two groups were recorded. Results The bleeding time in the observation group was (21.4 ± 7.8) h, shorter than that in the control group (34.7 ± 15.6) h (P <0.05). The bleeding rate in the observation group was 85.7% at 24 h <0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). Conclusion The clinical application of octreotide in the treatment of patients with digestive system hemorrhage can not only shorten the time of hemostasis, but also increase the rate of hemostasis effectively, which has some promotion and application value.